COMMUNIQUÉS West-GlobeNewswire

Imagin Medical Reports Research Study Progress

17/07/2018 - 22:30

VANCOUVER, British Columbia and BOSTON, July 17, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTCQB:IMEXF) (Frankfurt:DPD2) (Stuttgart:DPD2) (“Imagin” or the “Company”) announced today favorable results in the 10- [...]

Cara Therapeutics Announces Proposed Offering of Common Stock

17/07/2018 - 22:23

STAMFORD, Conn., July 17, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate [...]

AC Immune Announces Offerings and Issuance of up to 10 Million Common Shares

17/07/2018 - 22:09

Lausanne, Switzerland, July 17, 2018 - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company focused on neurodegenerative diseases, today announced that it is commencing offerings of up to [...]

ICU Medical, Inc. Announces Time of Second Quarter 2018 Earnings Conference Call

17/07/2018 - 22:05

SAN CLEMENTE, Calif., July 17, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care [...]

Minerva Neurosciences Elects Jeryl Hilleman to Board of Directors

17/07/2018 - 22:05

WALTHAM, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]

Veritas Pharma Signs IP Agreement with UK’s First Medicinal Cannabis Investment Fund

17/07/2018 - 22:05

VANCOUVER, British Columbia, July 17, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that it has signed an Intellectual Property [...]

CytomX Therapeutics Announces Closing of Public Offering of Common Stock

17/07/2018 - 22:01

SOUTH SAN FRANCISCO, Calif., July 17, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]

Orion Biotechnology Awarded a $2M Grant from National Center for Research and Development to Fund Further Development of its HIV Microbicide

17/07/2018 - 21:01

OTTAWA, July 17, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that its European subsidiary, Orion Biotechnology Polska Sp. z o.o., was awarded a [...]

bioAffinity Technologies Opens Test Validation Trial of CyPath® Lung

17/07/2018 - 20:40

SAN ANTONIO, July 17, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced it has commenced its test validation trial for CyPath® Lung, an advanced flow [...]

Tabula Rasa HealthCare Hosts Inaugural PACE Executive Director Advisory Meeting

17/07/2018 - 19:44

Goal: to confirm client priorities and perspectives related to future healthcare and changes for PACE MOORESTOWN, N.J., July 17, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare (TRHC) (NASDAQ:TRHC) held its annual [...]

Matrix Medical Network announces the appointment of Ian Worden as Vice President, Product & Marketing

17/07/2018 - 18:42

SCOTTSDALE, Ariz., July 17, 2018 (GLOBE NEWSWIRE) -- Matrix Medical Network (Matrix), a leading population health provider of in-home and mobile health services, has announced that Ian Worden has joined the company as [...]

Virbac : Revenue grew by +4.3% at constant exchange rates in the second quarter of 2018

17/07/2018 - 17:41

Key figures Net revenue 1 st half 2018- Provisional €429.7 million Total growth -1.8% Growth at constant exchange rates 1 +3.8% Growth at constant scope 1 +3.8% of which companion animals +5.0% (+8.5% excl. USA) food [...]

Virbac : chiffre d'affaires en croissance de +4,3% à taux de change constants au deuxième trimestre 2018

17/07/2018 - 17:41

CHIFFRES CLÉS Chiffre d'affaires du 1 er semestre 2018 - Provisoire 429,7 m€ Évolution globale -1,8% Croissance à taux de change constants +3,8% Croissance à change et périmètre constants 1 +3,8% dont animaux de [...]

The Alliance for Regenerative Medicine Releases List of Presenting Companies at the 2018 Cell & Gene Meeting on the Mesa

17/07/2018 - 17:41

WASHINGTON, DC, July 17, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization for the cell and gene therapy and broader regenerative medicine sector, today [...]

GUERBET : Descriptif du programme de rachat d'actions autorisé par l'Assemblée Générale Mixte du 25 mai 2018

17/07/2018 - 17:01

Villepinte (France), le 17 juillet 2018 (17h00 heures CET) Le présent document a pour finalité de présenter le programme de rachat d'actions préalablement à sa réalisation, conformément aux dispositions de l'article 241 [...]

Tauriga Sciences Inc. Tenders One Time Cash Payment of $69,502.74 to GS Capital Partners LLC to Fully Repay and Retire the Remainder of the Outstanding Balance Pursuant to the October 17, 2017 $105,000 Face Value 8.00% Convertible Debenture

17/07/2018 - 16:31

NEW YORK, NY, July 17, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) (OTC PINK: TAUGD) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]

Micron Products, Inc. Awarded U.S. Patent

17/07/2018 - 16:28

FITCHBURG, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Micron Products, Inc., a wholly owned subsidiary of Micron Solutions, Inc. (NYSE American:MICR), (together “Micron” or “the Company”) announces today that the Company [...]

Rubicon Organics™ Capitalizes on the Organic Movement -- CFN Media

17/07/2018 - 16:00

SEATTLE, WA, July 17, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article that [...]

GeneriCo, LLC Completes Transaction

17/07/2018 - 15:49

ST. LOUIS, July 17, 2018 (GLOBE NEWSWIRE) -- GeneriCo, LLC (GeneriCo), a specialty generic drug company, today announced that it completed a deal transaction with a leading US generic pharmaceutical company for the [...]